about the author

Amber Tong

amber@endpointsnews.com @AmberTongPW
Amber Tong on LinkedIn

author articles

Eli Lil­ly ush­ers up-and-com­ing GIP/GLP-1 drug in­to PhI­II as No­vo Nordisk ri­val wows with im­pres­sive re­sults

7 years ago
R&D

Three sci­en­tists share No­bel for pi­o­neer­ing work on phage dis­play and en­zymes; Kite antes up $10M in TCR dis­cov­ery ...

7 years ago
News Briefing

Paratek caps 20-year R&D jour­ney with FDA OK for its broad spec­trum an­tibi­ot­ic — time to talk launch

7 years ago
Pharma

F-Prime's Ben Aus­pitz co-leads $30M Se­ries A with Or­biMed for his lat­est rare dis­ease ven­ture

7 years ago
Financing
Startups

Buck­ing the trend, Antares gains FDA OK for testos­terone in­jec­tion on sec­ond try

7 years ago
Pharma

Nas­daq wraps up Q3 with IPO pitch­es from Gami­da Cell, NGM, Arog to­talling $219M

7 years ago
Financing

Can­cer R&D stars Jim Al­li­son, Tasuku Hon­jo award­ed No­bel prize for im­munother­a­py dis­cov­er­ies

7 years ago
People

Fred Aslan re­turns to biotech as pres­i­dent of Vi­vid­ion; Zai Lab scoops Por­to­la's Tao Fu to spear­head US op­er­a­tions

7 years ago
Peer Review

Gen­script re­bounds on HKEX with staunch de­fense of Leg­end Biotech's CAR-T da­ta in­tegri­ty

7 years ago
China

New York can­cer cen­ter launch­es 'his­toric' JV to bring Cuban-de­vel­oped can­cer drugs to US

7 years ago
Financing

Scathing short at­tack from an ob­scure source ac­cus­es Nan­jing Leg­end of ma­nip­u­lat­ing CAR-T da­ta — Gen­script shares ...

7 years ago
China

AM­AG ex­pands ma­ter­nal health pipeline, bags late-stage or­phan drug for $12.5M

7 years ago
Pharma

Lyra pock­ets $29.5M to push ear, nose, throat ap­pli­ca­tions of im­plant tech from Langer, White­sides

7 years ago
Financing
Startups

Gilead­'s sto­ried hep C fran­chise will now in­clude a gener­ic drug op­er­a­tion

7 years ago
Pharma

Cash-strapped Gem­phire lets go of five staffers as it con­tends with a clin­i­cal hold

7 years ago
R&D

FDA lifts clin­i­cal hold on Sarep­ta's Duchenne MD gene ther­a­py, clear­ing the way to a quick launch of a piv­otal tri­al

7 years ago
Pharma

Phase­Bio de­tails dol­lars in As­traZeneca deal as it rolls out a plan for $86M-plus IPO

7 years ago
Financing

Ex-Cas­ca­di­an chief Scott My­ers lands at Bio­Clin; Ko­di­ak woos Genen­tech vet Ja­son Ehrlich for CMO role

7 years ago
Peer Review

No­var­tis drums up EU launch plans as CHMP gives thumbs up to Spark's gene ther­a­py Lux­tur­na

7 years ago
Cell/Gene Tx

Nas­daq pa­rade march­es on as ex-Gen­mab crew at Y-mAbs reaps $96M

7 years ago
Financing

Ron De­Pin­ho rais­es seed cash for MD An­der­son col­league's work on a 'Holy Grail mol­e­cule' in can­cer, in­flam­ma­tion

7 years ago
Financing
Startups

With new $10.6B fund, Hill­house Cap­i­tal sets the stage for splashy Asia-fo­cused biotech deals

7 years ago
Financing
Startups

Two Genen­tech vets re­unite at Im­mune-Onc to help steer its $33M dri­ve to the clin­ic

7 years ago
Financing

WuXi AppTec files for pub­lic list­ing in Hong Kong four months af­ter ex­plo­sive Shang­hai IPO

7 years ago
Financing
China
First page Previous page 110111112113114115116 Next page Last page
A service from the Financial Times